What is the recommended evaluation and management for a patient with an abnormal toe‑brachial index (TBI < 0.7)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Abnormal Toe-Brachial Index (TBI < 0.7)

An abnormal TBI ≤0.70 confirms the diagnosis of peripheral artery disease (PAD) and mandates initiation of guideline-directed medical therapy (GDMT) for cardiovascular risk reduction, along with evaluation for potential revascularization if symptoms or tissue loss are present. 1, 2

Diagnostic Confirmation and Interpretation

  • A TBI ≤0.70 is the established threshold for diagnosing PAD, particularly valuable when ankle-brachial index (ABI) is unreliable due to noncompressible arteries (ABI >1.4), which commonly occurs in diabetes and chronic kidney disease. 1, 2

  • More refined TBI thresholds based on recent data suggest: normal TBI >0.8, borderline 0.61-0.8, abnormal ≤0.6, and severe PAD ≤0.2, with a TBI <0.6 having 95% positive predictive value for PAD. 3

  • TBI can be obtained in 92.7% of patients overall and in 82% of limbs where ABI is unobtainable, making it highly feasible for PAD diagnosis. 3

Immediate Clinical Actions

Cardiovascular Risk Stratification and Medical Therapy

  • Initiate comprehensive GDMT immediately, as patients with abnormal TBI have significantly increased cardiovascular morbidity and mortality compared to those with normal values. 1

  • Implement aggressive atherosclerotic risk factor modification including:

    • Antiplatelet therapy
    • High-intensity statin therapy
    • Blood pressure control
    • Diabetes management if present
    • Smoking cessation 1

Prognostic Implications

  • Low TBI is associated with significantly decreased patient survival (42±20 versus 51±16 months in patients with normal TBI, p=0.011), independent of ABI values. 4

  • Isolated low TBI (TBI <0.75 with ABI ≥0.90) carries similar mortality risk as combined foot-leg ischemia (both TBI and ABI abnormal), with progressive decline in survival across ischemia severity groups. 4

Symptom Assessment and Revascularization Evaluation

For Asymptomatic Patients

  • Apply GDMT and preventive foot care as primary management strategy. 1

  • Monitor for development of symptoms including claudication, rest pain, or tissue loss. 1

For Symptomatic Patients or Tissue Loss

  • Refer for vascular imaging (duplex ultrasound, CT angiography, or conventional angiography) to define anatomic disease and plan potential revascularization. 1, 2

  • Patients with isolated low TBI require revascularization at rates similar to those with low ABI, with angioplasty rates of 19.4% versus 3.2% in non-ischemic patients (p=0.033). 4

  • For chronic limb-threatening ischemia (CLTI), additional hemodynamic criteria include:

    • Ankle pressure <50 mmHg
    • Toe pressure <30 mmHg
    • Transcutaneous oxygen pressure (TcPO₂) <30 mmHg 2

Special Populations

Diabetic Patients

  • TBI demonstrates superior validity in diabetics compared to ABI, with sensitivity 0.88, specificity 0.88, and negative predictive value 0.97 for detecting significant stenosis. 5

  • Diabetic patients with foot ulceration and isolated low TBI achieve similar healing rates to non-ischemic patients (68% versus 60% over 12 months) when appropriately revascularized. 4

Patients with Renal Disease

  • TBI is particularly valuable in dialysis populations where vessel calcification renders ABI unreliable, though measurement protocols require standardization. 6

Critical Pitfalls to Avoid

  • Do not rely solely on ABI in patients with diabetes or chronic kidney disease, as noncompressible tibial arteries frequently produce falsely elevated ABI >1.4 despite significant PAD. 1, 2

  • Do not dismiss borderline TBI values (0.61-0.8) as these patients may still have clinically significant disease requiring close monitoring. 3

  • Do not delay GDMT initiation while awaiting further vascular imaging, as cardiovascular risk reduction should begin immediately upon PAD diagnosis. 1

  • Ensure proper measurement technique with 5-10 minutes supine rest, photoplethysmography probe on distal pulp of first or second toe, and comparison to higher brachial pressure. 2

Wound Healing Assessment

  • For patients with wounds, TBI >0.6 generally indicates adequate perfusion for healing potential, while TBI <0.6 typically requires revascularization consideration. 3, 7

  • Resting TcPO₂ >30 mmHg is a favorable indicator of wound healing, while <10 mmHg is associated with poor prognosis for healing and amputation risk. 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.